treatment
Serum levels of cVCAM-1 decreased by -19% (CI: -25%        to -13%) after treatment with fosinopril (P = .003) and were no longer different        from those of the control group.
Serum levels of cVCAM-1 decreased by -19% (CI: -25%        to -13%) after  @SUBJECT$   @PREDICAT$   @OBJECT$  (P = .003) and were no longer different        from those of the control group.